Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis

Abstract Introduction In this retrospective analysis, we evaluate the effectiveness of the potassium (K+) binder sodium zirconium cyclosilicate (SZC) in maintaining normokalemia and facilitating the initiation, optimization, and maintenance of renin–angiotensin–aldosterone system inhibitors (RAASi)...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Rhys Williams, William Ford, Alexander James, Kerys Thomas, Aaron Wong
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Adis, Springer Healthcare 2024-11-01
Reeks:	Cardiology and Therapy
Onderwerpen:	Heart failure Hyperkalemia Renin–angiotensin–aldosterone system inhibitor Sodium zirconium cyclosilicate
Online toegang:	https://doi.org/10.1007/s40119-024-00388-z
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!